We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Submit a Manuscript to the Journal

Annals of Medicine

For an Article Collection on

Gut Microbiome in Inflammatory Bowel Disease

Manuscript deadline
31 July 2023

Cover image - Annals of Medicine

Article collection guest advisor(s)

Atsushi Sakuraba, University of Chicago Medicine, Chicago, Illinois, USA
[email protected]

Jacob E. Ollech, Tel Aviv University, Petah Tikva, Israel
[email protected]

Submit an ArticleVisit JournalArticles

Gut Microbiome in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic immune-mediated disease affecting the gastrointestinal tract, affecting over 10 million people worldwide. IBD is thought to develop due to interactions between environmental, microbial, and immune-mediated factors in a genetically susceptible host. In patients with IBD, there is a breakdown of the multiple strategies that the immune system has evolved to promote the separation between its response to symbiotic microorganisms, pathogenic microorganisms, and the intestinal epithelium.

The gut microbiome has been proposed as one of the key players in the IBD pathogenesis -gene mutations, altered composition and structure, dysbiosis, and microbiome-driven immune responses of gut microbiome have been found among patients with IBD. Despite the emerging evidence in microbiome-immune interactions and epidemiologic observations implicating microbiome-modulating risk factors, the exact cause of IBD remains indistinct, and the role of gut microbiome in IBD pathogenesis is hugely unrevealed. Understanding the role of gut microbiome and the complex interactions between intestinal microorganisms and the host may provide crucial insights into the pathogenesis of IBD as well as new avenues of diagnosis, prevention, and treatment of the disease.

For this Article Collection, the goal is to solicit submission of any articles to understand the role of gut microbiome in IBD and findings in the gut microbiome related pathogenesis, diagnosis, and treatment of IBD, including laboratory investigations, clinical trials, and literature reviews into the subtopics highlighted below:

  • Gut microbiome structure in IBD
  • Interaction between the gut microbiome and intestinal barrier in IBD
  • Interaction between immune cells and gut microbiome in IBD
  • Gut microbiome-derived metabolites in IBD
  • Omics studies of gut microbiome in IBD
  • Gut microbiome dysbiosis in IBD
  • Gut microbiome-targeted treatments in IBD

Annals of Medicine accepts the following types of articles:

  • Research Articles
  • Clinical Studies
  • Systematic Reviews and Meta-Analyses
  • Review Articles
  • Mini Reviews
  • Case Series

When submitting your article, please select the section, 'Gastroenterology and Hepatology', and the Special Issue, 'Gut Microbiome in Inflammatory Bowel Disease' from the drop-down menu on the submission system.

Benefits of publishing open access within Taylor & Francis

Global marketing and publicity, ensuring your research reaches the people you want it to.

Article Collections bring together the latest research on hot topics from influential researchers across the globe.

Rigorous peer review for every open access article.

Rapid online publication allowing you to share your work quickly.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.